Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -3317.65% is 100% below its 5-year average of 7575529.28%, near the low end of its 5-year range (-3317.65%–83335500.00%).
234.10% below its 12-month average of -993.02%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2025-12-31): -1986.04%.
OPERATING MARGIN
-3317.65%
OPERATING MARGIN AVG TTM
-993.02%
OPERATING MARGIN AVG 3Y
10416440.99%
OPERATING MARGIN AVG 5Y
7575529.28%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-234.10%
CURRENT VS 3Y AVG
-100.03%
CURRENT VS 5Y AVG
-100.04%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Gelteq Limited Ordinary Shares
Market Cap
$5.32M
Operating Margin
-3317.65%
TTM Avg
-993.02%
3Y Avg
10416440.99%
5Y Avg
7575529.28%
Market Cap
$5.31M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1423.89%
5Y Avg
-7655.73%
Market Cap
$5.35M
Operating Margin
-1683.01%
TTM Avg
-1461.09%
3Y Avg
-2100.59%
5Y Avg
-1711.35%
Market Cap
$5.24M
Operating Margin
-305.03%
TTM Avg
-323.91%
3Y Avg
-495.10%
5Y Avg
-376.97%
Market Cap
$5.22M
Operating Margin
0.00%
TTM Avg
-62.53%
3Y Avg
-159.78%
5Y Avg
-184.56%
Market Cap
$5.21M
Operating Margin
-19.28%
TTM Avg
1.28%
3Y Avg
11.60%
5Y Avg
11.60%
Market Cap
$5.21M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.12M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.63M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gelteq Limited Ordinary Shares (GELS) | $5.32M | -3317.65% | -993.02% | 10416440.99% | 7575529.28% |
| Soligenix, Inc. (SNGX)vs › | $5.31M | 0.00% | 0.00% | -1423.89% | -7655.73% |
| Lexaria Bioscience Corp. (LEXX)vs › | $5.35M | -1683.01% | -1461.09% | -2100.59% | -1711.35% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.24M | -305.03% | -323.91% | -495.10% | -376.97% |
| Pulmatrix, Inc. (PULM)vs › | $5.22M | 0.00% | -62.53% | -159.78% | -184.56% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.21M | -19.28% | 1.28% | 11.60% | 11.60% |
| Alzamend Neuro Inc (ALZN)vs › | $5.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 0.00% | 0.00% | 0.00% | 0.00% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $4.97M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
100.0%
Operating Margin
-3317.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2025-12-31 | -1986.04% |
| 2025-09-30 | -1986.04% |
| 2025-06-30 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-06-30 | 83335500.00% |
| 2023-03-31 | 0.00% |
| 2022-06-30 | -705.90% |
| 2022-03-31 | 0.00% |
| 2021-06-30 | 0.00% |
